Both in Pharmaceuticals
Actinium Pharmaceuticals vs Biote
Over the past year ATNM returned −29.6% and BTMD returned −58.5%; their daily moves had a correlation of 0.01.
ATNM −29.6% BTMD −58.5%Growth of $1, one year, split-adjusted
| Metric | ATNM | BTMD |
|---|---|---|
| Price | $1.14 | $1.24 |
| Market cap | $35.8M | $35.6M |
| Today | −3.39% | +0.81% |
| 1 month | +12.9% | −21.0% |
| 6 months | +15.2% | −4.6% |
| Year to date | −16.2% | −52.3% |
| 1 year | −29.2% | −58.5% |
| Revenue growth (YoY) | — | −9.5% |
| Gross margin | 100.0% | 65.4% |
| Net margin | 79.7% | −14.8% |
| P/E (TTM) | 3.2× | 6.1× |
| Price / sales | 1.0× | 0.2× |
| Net cash | $36.5M | -$110.3M |
| Dividend yield | — | — |
| Volatility (60d) | 75.8% | 96.1% |
| Short % of float | 2.3% | 5.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).